Azzalure

Galderma webinar on neuromodulation with Aesthetics

Learn how you and your patients can have it both ways.

ADVERTORIAL: What a Difference a Year Makes

A year ago, Medfx and Galderma formed an exclusive partnership as the retailer became the sole distributor of the pharmaceutical giant’s aesthetics portfolio in the UK and Ireland

Galderma appoints new PRs

Global pharmaceutical company Galderma has appointed Kendrick PR and Mantlepiece PR as its new UK representatives.

AbobotulinumtoxinA efficacy confirmed in phase 2 study

Global pharmaceutical company Galderma has received top-line results for its phase 2 study in the US on the efficacy and safety of a single dose of abobotulinumtoxinA versus placebo for the treatment of moderate to severe glabellar lines.

High satisfaction rates recorded with six-monthly Azzalure treatment

A study from global pharmaceutical company Galderma has indicated that 95% of patients treated with Azzalure abobotulinum toxin A achieved high levels of satisfaction with two treatments per year.

Second Aesthetics webinar dubbed ‘excellent’ by attendees

On June 17, more than 250 medical professionals tuned in to the second webinar hosted by Aesthetics and supported by Galderma UK.

Galderma celebrates 10-year toxin anniversary

On May 14, pharmaceutical company Galderma (UK) Limited celebrated 10 years since Azzalure®(AbobotulinumtoxinA) was first approved in Europe for the treatment of glabellar lines.

Galderma confirms Med-fx as sole-preferred distributor

Pharmaceutical company Galderma (UK) Limited and aesthetic and skincare product supplier Med-fx Ltd will launch new, enhanced packages of customer-centric support services for healthcare professionals who purchase products marketed under the Azzalure and Restylane brands in the UK and Ireland from September 8.

Study demonstrates high patient satisfaction with Azzalure

The results of two studies conducted by pharmaceutical company Galderma (UK) Limited have demonstrated high patient satisfaction for the use of Azzalure (AbobotulinumtoxinA), its botulinum toxin type A product, in the glabellar complex.

Azzalure in Action (abobotulinum toxin type A) webinar – what to expect

The highly anticipated Aesthetics Media webinar, titled Azzalure (abobotulinum toxin type A) in Action: Key Principles and Treatment for Glabellar Lines in association with pharmaceutical company Galderma UK, is taking place on June 17 from 7pm. It will last approximately one hour.

Aesthetics

Partner with us

Advisory Boards

Articles

TOPIC AREA

Aesthetics Journal

Aesthetics membership

Become a member today

Basic

Free

Enhanced

£95 (inc VAT)

Elite

£190 ( inc VAT)

CPD

Training and Education

Global Events

Resources

Company directory

Jobs

Buy & Sell

Aesthetics equipmentmarketplace